These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 26232454)

  • 1. Senescent profile of angiogenic T cells from systemic lupus erythematosus patients.
    López P; Rodríguez-Carrio J; Martínez-Zapico A; Caminal-Montero L; Suarez A
    J Leukoc Biol; 2016 Mar; 99(3):405-12. PubMed ID: 26232454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus.
    Bortoluzzi A; Chighizola CB; Fredi M; Raschi E; Bodio C; Privitera D; Gonelli A; Silvagni E; Govoni M; Cavazzana I; Airò P; Meroni PL; Tincani A; Franceschini F; Piantoni S; Casciano F
    Front Immunol; 2020; 11():572876. PubMed ID: 33193356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD45RA-Foxp3(high) activated/effector regulatory T cells in the CCR7 + CD45RA-CD27 + CD28+central memory subset are decreased in peripheral blood from patients with rheumatoid arthritis.
    Matsuki F; Saegusa J; Miyamoto Y; Misaki K; Kumagai S; Morinobu A
    Biochem Biophys Res Commun; 2013 Sep; 438(4):778-83. PubMed ID: 23747721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic CD4+CD28 null T lymphocytes, systemic inflammation and atherosclerotic risk in patients with chronic kidney disease.
    Yadav AK; Lal A; Jha V
    Nephron Clin Pract; 2012; 120(4):c185-93. PubMed ID: 22907478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of CD4+CD28null T cells in patients with coronary artery disease and individuals with risk factors for atherosclerosis.
    Téo FH; de Oliveira RT; Mamoni RL; Ferreira MC; Nadruz W; Coelho OR; Fernandes Jde L; Blotta MH
    Cell Immunol; 2013 Jan; 281(1):11-9. PubMed ID: 23416719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4⁺CD28null T lymphocytes resemble CD8⁺CD28null T lymphocytes in their responses to IL-15 and IL-21 in HIV-infected patients.
    Echeverría A; Moro-García MA; Asensi V; Cartón JA; López-Larrea C; Alonso-Arias R
    J Leukoc Biol; 2015 Sep; 98(3):373-84. PubMed ID: 26034206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4
    Kosmaczewska A; Ciszak L; Stosio M; Szteblich A; Madej M; Frydecka I; Wiland P; Szmyrka M
    Lupus; 2020 Jun; 29(7):705-714. PubMed ID: 32279585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An imbalance in the T-helper phenotypes displayed by senescent CD4
    Lozada-Navarro AC; Castillo-Martínez D; Moreno-Ramírez M; Acosta-Peña G; Páez A; Massó F; Márquez-Velasco R; Amezcua-Guerra LM
    Lupus; 2018 Nov; 27(13):2155-2160. PubMed ID: 30111238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
    Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
    Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Angiogenic T Cells and Their Subpopulations in Patients with Systemic Lupus Erythematosus.
    Miao J; Qiu F; Li T; Zhao P; Zhang K; Lv M; Wan J; Qi X; Zhu P
    Mediators Inflamm; 2016; 2016():2842143. PubMed ID: 27065298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating CD4+CD28null and extra-thymic CD4+CD8+ double positive T cells are independently associated with disease damage in systemic lupus erythematosus patients.
    Ugarte-Gil MF; Sánchez-Zúñiga C; Gamboa-Cárdenas RV; Aliaga-Zamudio M; Zevallos F; Tineo-Pozo G; Cucho-Venegas JM; Mosqueira-Riveros A; Medina M; Perich-Campos RA; Alfaro-Lozano JL; Rodriguez-Bellido Z; Alarcón GS; Pastor-Asurza CA
    Lupus; 2016 Mar; 25(3):233-40. PubMed ID: 26385221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell senescence was correlated with early atherosclerosis in patients with systemic lupus erythematosus.
    Pratama MZ; Wahono CS; Aslam ABN; Chilmi S; Sari VP; Abdurrohman A; Sulistiyowati I; Aditya A; Johono MF; Robert
    Int J Rheum Dis; 2024 Sep; 27(9):e15339. PubMed ID: 39278724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+CD28-, suppressive T cells in systemic lupus erythematosus.
    Tulunay A; Yavuz S; Direskeneli H; Eksioglu-Demiralp E
    Lupus; 2008 Jul; 17(7):630-7. PubMed ID: 18625635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: Senescent angiogenic T cells: the use of CD28 makes the difference in endothelial homeostasis.
    Della Bella S; Mavilio D
    J Leukoc Biol; 2016 Mar; 99(3):399-401. PubMed ID: 26932386
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon-α-induced B-lymphocyte stimulator expression and mobilization in healthy and systemic lupus erthymatosus monocytes.
    López P; Scheel-Toellner D; Rodríguez-Carrio J; Caminal-Montero L; Gordon C; Suárez A
    Rheumatology (Oxford); 2014 Dec; 53(12):2249-58. PubMed ID: 24942493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-22+CD4+ T-cells in patients with active systemic lupus erythematosus.
    Zhao L; Jiang Z; Jiang Y; Ma N; Wang K; Zhang Y; Feng L
    Exp Biol Med (Maywood); 2013 Feb; 238(2):193-9. PubMed ID: 23576801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imbalance between CD8
    Minning S; Xiaofan Y; Anqi X; Bingjie G; Dinglei S; Mingshun Z; Juan X; Xiaohui J; Huijuan W
    Lupus; 2019 Sep; 28(10):1214-1223. PubMed ID: 31399013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 21 correlates with T cell and B cell subset alterations in systemic lupus erythematosus.
    Terrier B; Costedoat-Chalumeau N; Garrido M; Geri G; Rosenzwajg M; Musset L; Klatzmann D; Saadoun D; Cacoub P
    J Rheumatol; 2012 Sep; 39(9):1819-28. PubMed ID: 22859347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-density granulocytes and monocytes as biomarkers of cardiovascular risk in systemic lupus erythematosus.
    López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; Suárez-Díaz S; Mozo L; Benavente L; Caminal-Montero L; Suárez A
    Rheumatology (Oxford); 2020 Jul; 59(7):1752-1764. PubMed ID: 32031658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased interleukin 21 and follicular helper T-like cells and reduced interleukin 10+ B cells in patients with new-onset systemic lupus erythematosus.
    Wang L; Zhao P; Ma L; Shan Y; Jiang Z; Wang J; Jiang Y
    J Rheumatol; 2014 Sep; 41(9):1781-92. PubMed ID: 25028374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.